Cross-cultural adaptation and validation of the Behcet’s Disease Current Activity Form in Korea
Hyo Jin Choi, Mi Ryoung Seo, Hee Jung Ryu, Han Joo Baek
Korean J Intern Med. 2015;30(5):714-718. Published online 2015 Aug 27 DOI: https://doi.org/10.3904/kjim.2015.30.5.714
Citations to this article as recorded by 
A review of patient-reported outcome measures used in uveitis
Mallika Prem Senthil, Sumu Simon, Paul A. Constable
Survey of Ophthalmology.2023; 68(2): 225. CrossRef
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review
Marta Arbrile, Massimo Radin, Davide Medica, Paolo Miraglia, Letizia Rilat, Irene Cecchi, Silvia Grazietta Foddai, Alice Barinotti, Elisa Menegatti, Dario Roccatello, Savino Sciascia
International Journal of Molecular Sciences.2023; 24(3): 3041. CrossRef
Validity and reliability of a checklist for patients with Behçet’s disease based on the International Classification of Functioning, Disability and Health
Hideyo Tsutsui, Hirotoshi Kikuchi, Hiroko Oguchi, Hajime Kono, Takayoshi Ohkubo
Rheumatology International.2022; 42(1): 159. CrossRef
Integrative Medicine (Herbal Medicine Combined with Drug Therapy) for Behcet’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Ji Hee Jun, Lin Ang, Tae Young Choi, Hye Won Lee, Myeong Soo Lee
Pharmaceutics.2021; 13(4): 476. CrossRef
The pattern of cardiovascular manifestations in Egyptian Behçet’s patients and its relation to disease activity
Nashwa Aly Morshedy, Dalia Fayez Mohammed, Fatma Mohammed Badr, Mohammed Abd El monem Teama
The Egyptian Journal of Internal Medicine.2021;[Epub] CrossRef
Development of an Arabic version of the Behçet’s Disease Current Activity Form (Ar-BDCAF): cross-cultural adaptation and validation initiative in Egypt
Tamer A. Gheita, Hanan M. Fathi, Nahla N. Eesa, Emad El-Shebini, Samar Tharwat, Nevin Hammam, Rasha M. Fawzy, Rawhya R. El-Shereef, Mona H. Abd El-Samea, Rasha A. Abdel Noor, Mohamed N. Salem, Abdel Hafeez Moshrif, Ahmed Elsaman, Amany R. El-Najjar, Amira
Clinical Rheumatology.2021; 40(11): 4609. CrossRef
Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease
Marta Arbrile, Massimo Radin, Daniela Rossi, Elisa Menegatti, Simone Baldovino, Savino Sciascia, Dario Roccatello
Frontiers in Immunology.2021;[Epub] CrossRef
Increased serum interleukin‐32 levels in patients with Behçet's disease
You‐Jung Ha, Jin‐Su Park, Mi‐il Kang, Soo‐Kon Lee, Yong‐Beom Park, Sang‐Won Lee
International Journal of Rheumatic Diseases.2018; 21(12): 2167. CrossRef
CXCL10/CXCR3 axis is associated with disease activity and the development of mucocutaneous lesions in patients with Behçet’s disease
Sang Jin Lee, Shin Eui Kang, Eun Ha Kang, Byoong Yong Choi, Katherine Masek-Hammerman, Jameel Syed, Yutian Zhan, Kathleen Neff-Phillips, Jin Kyun Park, Eun Young Lee, Eun Bong Lee, Yeong Wook Song
Scientific Reports.2017;[Epub] CrossRef
Behçet's Disease Current Activity Form as a Patient's Derived Measure
Hyo Jin Choi, Mi Ryoung Seo, Hee Jung Ryu, Han Joo Baek
Journal of Rheumatic Diseases.2016; 23(1): 19. CrossRef
Validation and reliability of a Behcet’s Syndrome Activity Scale in Korea
Hyo Jin Choi, Mi Ryoung Seo, Hee Jung Ryu, Han Joo Baek
The Korean Journal of Internal Medicine.2015; 31(1): 170. CrossRef